Retinol is one of the scariest ingredients I don't wanna try
Arch Ophthalmol 1979;97:1086-1088
42 ForouhariA.Heidari-BeniM.VeisiS.PoursafaP.KelishadiR
A recent Phase 2 randomised placebo-controlled trial tested efinopegdutide in people with obesity over a 26-week period, where participants were randomly assigned weekly treatment with either placebo, 5 mg, 7.4 mg, 10 mg efinopegdutide, or 3 mg liraglutide daily
Acheson KJ, Zahorska-Markiewicz B, Pittet P, Anantharaman K, Jquier E
complexity introduces more points of failure (contamination, dosing errors)